What changes for testosterone therapy after 50
The test for low testosterone does not change at 50, but the safety checks around treatment do. Prostate problems, heart disease and thick blood all become more common with age, and each one can be affected by testosterone. So three things are added to the plan: a baseline PSA with a prostate symptom check, a cardiovascular risk review before the first dose, and a fixed schedule of hematocrit and PSA rechecks.
The diagnosis itself still needs two low early-morning tests and symptoms that fit, with other causes looked for. The FDA’s 2025 class-wide labeling update kept the labels’ limitation of use for age-related low testosterone, which is why the workup aims for a clear cause rather than treating a number that simply drifted with age. Our answer on whether TRT is FDA-approved for age-related low T explains that distinction.
A baseline PSA and prostate symptom check
Before the first dose, every man over 50 has a PSA test and is asked about urinary symptoms. The Endocrine Society guideline resources recommend assessing prostate cancer risk before starting testosterone in men aged 55 to 69, and they list prostate cancer, a prostate nodule, or a PSA above 4 ng/mL (above 3 ng/mL in men at high risk) without urological evaluation among reasons not to start. Severe lower urinary tract symptoms are also on that list.
The symptom check matters because an enlarged prostate is common. The NIDDK describes symptoms such as a weak stream, getting up at night to urinate, urgency and a feeling of not emptying fully. Mild symptoms do not rule out treatment, but they are recorded so any change on testosterone can be judged against them. Our page on an enlarged prostate and testosterone covers that overlap.
A PSA result also needs context. MedlinePlus notes that an enlarged prostate or prostatitis can raise PSA, and that ejaculation in the 24 hours before the test can too. A high first result is often repeated before conclusions are drawn. See high PSA before TRT.
A cardiovascular risk review before the first dose
Heart risk is reviewed before treatment, not after. The largest safety trial so far, TRAVERSE, enrolled 5,246 men aged 45 to 80 with heart disease or high heart risk. Major heart events occurred in 7.0% of men on testosterone gel and 7.3% on placebo, so testosterone was judged noninferior. But the testosterone group had more atrial fibrillation, acute kidney injury and pulmonary embolism.
The FDA’s 2025 update removed boxed warning language about cardiovascular outcomes in light of TRAVERSE and added blood pressure warnings across testosterone products, after monitoring studies showed blood pressure rises. The review before your first dose therefore covers:
- blood pressure, measured properly and, if borderline, at home;
- lipids, ApoB and A1c;
- any heart attack or stroke, especially in the past six months, and heart failure, which the Endocrine Society lists as reasons not to start until controlled;
- irregular heartbeat, past blood clots or a clotting disorder;
- symptoms of sleep apnea.
Our article on the TRAVERSE trial and heart safety goes into the results.
Rechecks at three to six months, then yearly
After 50, the monitoring schedule is fixed in advance. The Endocrine Society guideline recommends measuring hematocrit at baseline, at 3 to 6 months and then yearly, and advises stopping treatment if hematocrit rises above 54% until it comes down. For PSA, it suggests a recheck 3 to 12 months after starting. Ultimate Male rechecks both at three to six months, inside those windows, and then yearly.
| Check | Before starting | 3 to 6 months | Then | Acts on |
|---|---|---|---|---|
| Hematocrit | Yes | Yes | Yearly | Above 54%: pause and reassess |
| PSA | Yes | Yes | Yearly | Confirmed rise above 1.4 ng/mL in year one, or above 4.0 ng/mL: urology referral |
| Testosterone level | Two morning tests | Yes | As needed | Dose adjusted by your provider |
| Blood pressure | Yes | Yes | Every visit | Sustained rise: review dose, format or blood pressure care |
| Urinary symptoms | Yes | Yes | Yearly | Marked worsening: evaluation |
The urology thresholds come from the Endocrine Society guideline resources, which also recommend referral for an abnormal prostate exam. Our pages on rising PSA on TRT and hematocrit on TRT explain what happens if a recheck comes back high.
How age shapes the choice of format
After 50, the format is chosen partly for how easily it can be adjusted if a recheck comes back high. Injections and daily capsules can be changed or paused within days, which suits a man whose hematocrit or blood pressure needs watching. Pellets release testosterone over several months and cannot be turned down once placed, so they tend to suit men whose numbers are already stable on treatment.
Blood pressure is the other factor. Since the FDA now expects a blood pressure warning on every testosterone product, a man with borderline or treated hypertension is asked to check his pressure at home, and the oral option in particular comes with periodic blood pressure checks. Our page on testosterone injections versus pellets sets out the trade-offs side by side.
Questions to ask before you start
- Are my two morning tests low enough, and do my symptoms fit?
- Is my PSA normal for my age, and should it be repeated before I start?
- Do my urinary symptoms change anything?
- Is my blood pressure controlled well enough to begin?
- Which format suits my heart and blood pressure history?
- When exactly are my three-to-six-month and yearly rechecks?
Keep urgent symptoms separate from the plan. Chest pain, sudden shortness of breath, a painful swollen leg, or signs of a stroke such as facial droop or slurred speech mean calling 911.
How Ultimate Male approaches TRT after 50
It starts with a free 10-minute call, then the TRT pre-screening panel, which covers total testosterone, estradiol, PSA and a complete blood count and is bundled with your first consultation. Draws are done in the morning at our San Gabriel or Downey clinic, and a PA-C or MD adds heart markers and a repeat testosterone where needed. A consultation is an evaluation, so treatment is recommended only if the diagnosis and the safety checks both support it.
If you are past 60, our page for men over 60 covers the extra steps that apply. The options and how monitoring works are on our testosterone therapy page.
